vs
AMERICAN SHARED HOSPITAL SERVICES（AMS）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
RIVERVIEW BANCORP INC的季度营收约是AMERICAN SHARED HOSPITAL SERVICES的1.8倍（$14.0M vs $7.7M），RIVERVIEW BANCORP INC净利率更高（9.8% vs -8.2%，领先18.0%），RIVERVIEW BANCORP INC同比增速更快（10.4% vs -14.8%），RIVERVIEW BANCORP INC自由现金流更多（$-736.0K vs $-2.7M），过去两年RIVERVIEW BANCORP INC的营收复合增速更高（24.6% vs 21.7%）
美国共享医院服务公司为医疗机构提供放射治疗、立体定向放射外科及诊断成像设备的整体外包解决方案，免除医院高昂的前期资本投入，主要业务覆盖北美，同时服务拉美及部分亚太地区的公立、私立医院客户。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
AMS vs RVSB — 直观对比
营收规模更大
RVSB
是对方的1.8倍
$7.7M
营收增速更快
RVSB
高出25.2%
-14.8%
净利率更高
RVSB
高出18.0%
-8.2%
自由现金流更多
RVSB
多$2.0M
$-2.7M
两年增速更快
RVSB
近两年复合增速
21.7%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $7.7M | $14.0M |
| 净利润 | $-631.0K | $1.4M |
| 毛利率 | 11.7% | — |
| 营业利润率 | -18.1% | 12.4% |
| 净利率 | -8.2% | 9.8% |
| 营收同比 | -14.8% | 10.4% |
| 净利润同比 | 52.5% | 11.8% |
| 每股收益（稀释后） | $-0.09 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMSRVSB
| Q4 25 | $7.7M | $14.0M | ||
| Q3 25 | $7.2M | $13.6M | ||
| Q2 25 | $7.1M | $13.3M | ||
| Q1 25 | $6.1M | $12.9M | ||
| Q4 24 | $9.1M | $12.7M | ||
| Q3 24 | $7.0M | $12.8M | ||
| Q2 24 | $7.1M | $12.2M | ||
| Q1 24 | $5.2M | $9.0M |
净利润AMSRVSB
| Q4 25 | $-631.0K | $1.4M | ||
| Q3 25 | $-17.0K | $1.1M | ||
| Q2 25 | $-280.0K | $1.2M | ||
| Q1 25 | $-625.0K | $1.1M | ||
| Q4 24 | $-1.3M | $1.2M | ||
| Q3 24 | $-207.0K | $1.6M | ||
| Q2 24 | $3.6M | $966.0K | ||
| Q1 24 | $119.0K | $-3.0M |
毛利率AMSRVSB
| Q4 25 | 11.7% | — | ||
| Q3 25 | 22.1% | — | ||
| Q2 25 | 23.1% | — | ||
| Q1 25 | 15.4% | — | ||
| Q4 24 | 35.3% | — | ||
| Q3 24 | 19.6% | — | ||
| Q2 24 | 35.0% | — | ||
| Q1 24 | 41.1% | — |
营业利润率AMSRVSB
| Q4 25 | -18.1% | 12.4% | ||
| Q3 25 | -4.8% | 10.2% | ||
| Q2 25 | -7.7% | 11.7% | ||
| Q1 25 | -21.3% | 11.3% | ||
| Q4 24 | -20.2% | 12.4% | ||
| Q3 24 | -12.7% | 15.5% | ||
| Q2 24 | -0.0% | 10.0% | ||
| Q1 24 | -1.6% | -47.5% |
净利率AMSRVSB
| Q4 25 | -8.2% | 9.8% | ||
| Q3 25 | -0.2% | 8.1% | ||
| Q2 25 | -4.0% | 9.2% | ||
| Q1 25 | -10.2% | 8.9% | ||
| Q4 24 | -14.6% | 9.7% | ||
| Q3 24 | -3.0% | 12.2% | ||
| Q2 24 | 51.0% | 7.9% | ||
| Q1 24 | 2.3% | -34.7% |
每股收益（稀释后）AMSRVSB
| Q4 25 | $-0.09 | $0.07 | ||
| Q3 25 | $0.00 | $0.05 | ||
| Q2 25 | $-0.04 | $0.06 | ||
| Q1 25 | $-0.10 | $0.05 | ||
| Q4 24 | $-0.21 | $0.06 | ||
| Q3 24 | $-0.03 | $0.07 | ||
| Q2 24 | $0.55 | $0.05 | ||
| Q1 24 | $0.02 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.5M | $28.6M |
| 总债务越低越好 | $17.4M | — |
| 股东权益账面价值 | $24.0M | $164.2M |
| 总资产 | $55.5M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.72× | — |
8季度趋势，按日历期对齐
现金及短期投资AMSRVSB
| Q4 25 | $3.5M | $28.6M | ||
| Q3 25 | $5.1M | $32.8M | ||
| Q2 25 | $11.1M | $34.2M | ||
| Q1 25 | $11.2M | $29.4M | ||
| Q4 24 | $11.0M | $25.3M | ||
| Q3 24 | $13.8M | $31.0M | ||
| Q2 24 | $14.2M | $27.8M | ||
| Q1 24 | $12.8M | $23.6M |
总债务AMSRVSB
| Q4 25 | $17.4M | — | ||
| Q3 25 | $18.2M | — | ||
| Q2 25 | $19.1M | — | ||
| Q1 25 | $19.9M | — | ||
| Q4 24 | $20.4M | — | ||
| Q3 24 | $14.4M | — | ||
| Q2 24 | $15.1M | — | ||
| Q1 24 | $15.6M | — |
股东权益AMSRVSB
| Q4 25 | $24.0M | $164.2M | ||
| Q3 25 | $24.6M | $163.5M | ||
| Q2 25 | $24.5M | $162.0M | ||
| Q1 25 | $24.6M | $160.0M | ||
| Q4 24 | $25.2M | $158.3M | ||
| Q3 24 | $26.4M | $160.8M | ||
| Q2 24 | $26.5M | $155.9M | ||
| Q1 24 | $22.8M | $155.6M |
总资产AMSRVSB
| Q4 25 | $55.5M | $1.5B | ||
| Q3 25 | $59.6M | $1.5B | ||
| Q2 25 | $63.5M | $1.5B | ||
| Q1 25 | $63.3M | $1.5B | ||
| Q4 24 | $60.2M | $1.5B | ||
| Q3 24 | $63.3M | $1.5B | ||
| Q2 24 | $60.8M | $1.5B | ||
| Q1 24 | $50.1M | $1.5B |
负债/权益比AMSRVSB
| Q4 25 | 0.72× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.78× | — | ||
| Q1 25 | 0.81× | — | ||
| Q4 24 | 0.81× | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | 0.57× | — | ||
| Q1 24 | 0.68× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-704.0K | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | $-2.7M | $-736.0K |
| 自由现金流率自由现金流/营收 | -34.8% | -5.2% |
| 资本支出强度资本支出/营收 | 25.7% | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | $-8.5M | $20.4M |
8季度趋势，按日历期对齐
经营现金流AMSRVSB
| Q4 25 | $-704.0K | $-506.0K | ||
| Q3 25 | $1.7M | $16.8M | ||
| Q2 25 | $-372.0K | $-697.0K | ||
| Q1 25 | $2.5M | $8.3M | ||
| Q4 24 | $274.0K | $2.2M | ||
| Q3 24 | $472.0K | $764.0K | ||
| Q2 24 | $1.3M | $5.4M | ||
| Q1 24 | $-1.9M | $12.8M |
自由现金流AMSRVSB
| Q4 25 | $-2.7M | $-736.0K | ||
| Q3 25 | $-2.0M | $16.4M | ||
| Q2 25 | $-2.3M | $-773.0K | ||
| Q1 25 | $-1.5M | $5.6M | ||
| Q4 24 | $-4.4M | $1.9M | ||
| Q3 24 | $-407.0K | $-1.4M | ||
| Q2 24 | $70.0K | $5.3M | ||
| Q1 24 | $-3.0M | $7.1M |
自由现金流率AMSRVSB
| Q4 25 | -34.8% | -5.2% | ||
| Q3 25 | -28.3% | 120.1% | ||
| Q2 25 | -32.1% | -5.8% | ||
| Q1 25 | -24.7% | 43.1% | ||
| Q4 24 | -48.4% | 15.0% | ||
| Q3 24 | -5.8% | -11.3% | ||
| Q2 24 | 1.0% | 43.7% | ||
| Q1 24 | -58.4% | 79.0% |
资本支出强度AMSRVSB
| Q4 25 | 25.7% | 1.6% | ||
| Q3 25 | 51.6% | 2.9% | ||
| Q2 25 | 26.9% | 0.6% | ||
| Q1 25 | 65.7% | 21.0% | ||
| Q4 24 | 51.4% | 2.4% | ||
| Q3 24 | 12.6% | 17.3% | ||
| Q2 24 | 17.2% | 0.9% | ||
| Q1 24 | 22.7% | 62.0% |
现金转化率AMSRVSB
| Q4 25 | — | -0.37× | ||
| Q3 25 | — | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | — | 7.20× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | 0.36× | 5.63× | ||
| Q1 24 | -15.67× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMS
| Direct Patient Services | $4.0M | 51% |
| Rental Income From Medical Services | $2.7M | 35% |
| Pbrt Services | $1.2M | 15% |
RVSB
暂无分部数据
